Most Popular Stories
- Yelling, curses, insults: All in a day's work for docs, nurses
- Aetna's Ron Williams - CEO Compensation
- Illegal-immigrant issues may threaten passage of House reform bill
- CVS Caremark reports lost deals, FTC investigation
- Nurses in ICUs get worse sleep, may make more errors
- Humana slammed after posting 65 percent increase in third quarter profits
Featured Jobs
-
Internal Medicine Job in Indiana
StaffPointe, LLC - southwest, IN -
General Surgery Job in Missouri
StaffPointe, LLC - south central, MO -
Physician Assistant or Nurse Practitioner - Surgery 577
AVA Search Group - Southern, MN -
Neuroloigst Job for Indiana
StaffPointe, LLC - north, IN -
Pediatrician Job in Oklahoma
StaffPointe, LLC - north, OK
Events
- IHI's 21st Annual National Forum on Quality Improvement in Health Care
December 6-9 — Orlando, FL - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT - Mobile Healthcare Industry Summit
1-2 Dec 09 — London
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Hospital Fires | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Poll shows support for Democrats' healthcare agenda
All eyes are on Washington D.C. as Democrats regain control of Congress today, and one of the incoming party's top priorities will be making easier for Americans to buy cheaper prescription drugs from other countries. An Associated Press-AOL News poll found that 69 percent of respondents support legislation that would makes these inexpensive drugs easier to acquire. "Importing prescription drugs to the United States is illegal, but the FDA generally does not bar individuals from bringing in small amounts for personal use," explains the AP. Some medications cost significantly less in other countries than they do in the United States; however, officials don't think that this will force down the price of prescription drugs here.
To a lesser degree, the poll found that Americans also support the Democrats' plan to relieve restrictions on federal stem cell research funding. In July President Bush used his first-ever veto to reject a bill on embryonic stem-cell research that would have lifted the 2001 ban on public funding of stem cell research. Democrats say they will revive the issue, which could force the President to veto the bill again. Last time this bill was vetoed House lawmakers were unable to override his veto, falling just two votes short of the two-thirds majority it needed. The new Democratic majority promises to have a significant impact on the issue of federal funding for stem cell research.
For more on the poll:
- read this AP report
Related Articles:
Democratic win could be bad news for pharma industry. Report
Bush vetoes stem cell bill, override fails. Report
Fewer drugs coming in from Canada. Report
Related Stories
- Study: Some physicians uninformed about approved uses of drugs
- Nursing homes forced to address chronic pain management
- FL residents pushing for prescription drug registry
- Study: Prescription leaflets vary widely in quality
- Studies raise questions about how much drug safety info should be released
- Study: Medicaid paid $198 million for unapproved drugs
- Boston ends Canadian drug import program, citing lack of interest
- Congress overrides Bush veto on Medicare bill, stalling cuts
- FTC: Pharmas cut 14 deals to delay generic sales in '07
- FDA says hospitals may still have recalled heparin
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





